Chronic Spontaneous Urticaria in the Era of Targeted Therapy: From Pathogenic Mechanisms to Precision Medicine. (PubMed, Pharmaceutics) - Sep 27, 2026 - "Advances in understanding CSU pathogenesis have enabled the development of targeted therapies that may improve disease control. Predictive biomarkers and endotypic characterization may support the future development of more personalized therapeutic strategies; however, clinically validated biomarkers for treatment selection remain limited, and prospective validation of biomarker-guided approaches is still needed."
Journal • Review • Cardiovascular • Chronic Spontaneous Urticaria • Dermatology • Immunology • Inflammation • Urticaria
|
|
Joanna Gorka-Dynysiewicz; Klara Andrzejczak; Wiktor Witkowski
|